Beck Mack & Oliver LLC Invests $216,000 in Becton Dickinson and Co (BDX)

Beck Mack & Oliver LLC purchased a new position in shares of Becton Dickinson and Co (NYSE:BDX) in the 4th quarter, HoldingsChannel.com reports. The fund purchased 1,010 shares of the medical instruments supplier’s stock, valued at approximately $216,000.

Other large investors have also recently added to or reduced their stakes in the company. Westwood Holdings Group Inc. lifted its holdings in Becton Dickinson and by 24.2% during the 2nd quarter. Westwood Holdings Group Inc. now owns 1,056,487 shares of the medical instruments supplier’s stock worth $206,136,000 after purchasing an additional 205,721 shares during the last quarter. Colony Group LLC lifted its holdings in Becton Dickinson and by 2.1% during the 2nd quarter. Colony Group LLC now owns 11,889 shares of the medical instruments supplier’s stock worth $2,320,000 after purchasing an additional 239 shares during the last quarter. State Street Corp lifted its holdings in Becton Dickinson and by 3.5% during the 2nd quarter. State Street Corp now owns 10,270,221 shares of the medical instruments supplier’s stock worth $2,003,834,000 after purchasing an additional 342,873 shares during the last quarter. Peapack Gladstone Financial Corp raised its holdings in Becton Dickinson and by 1.3% in the 2nd quarter. Peapack Gladstone Financial Corp now owns 36,472 shares of the medical instruments supplier’s stock valued at $7,116,000 after acquiring an additional 453 shares in the last quarter. Finally, Zions Bancorporation raised its holdings in Becton Dickinson and by 23.7% in the 3rd quarter. Zions Bancorporation now owns 10,718 shares of the medical instruments supplier’s stock valued at $2,100,000 after acquiring an additional 2,050 shares in the last quarter. 75.68% of the stock is owned by institutional investors and hedge funds.

Becton Dickinson and Co (NYSE:BDX) opened at $224.82 on Tuesday. Becton Dickinson and Co has a 52 week low of $175.66 and a 52 week high of $248.39. The company has a quick ratio of 5.03, a current ratio of 5.58 and a debt-to-equity ratio of 1.44. The stock has a market capitalization of $51,580.00, a price-to-earnings ratio of 48.35, a PEG ratio of 1.69 and a beta of 1.12.

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 30th. Stockholders of record on Friday, March 9th will be paid a $0.75 dividend. The ex-dividend date is Thursday, March 8th. This represents a $3.00 annualized dividend and a dividend yield of 1.33%. Becton Dickinson and’s payout ratio is 64.52%.

Several equities analysts have weighed in on the company. Zacks Investment Research raised Becton Dickinson and from a “hold” rating to a “buy” rating and set a $259.00 price objective for the company in a report on Friday, January 19th. Bank of America reaffirmed a “buy” rating and issued a $260.00 price objective on shares of Becton Dickinson and in a report on Friday, January 19th. Citigroup raised Becton Dickinson and from a “sell” rating to a “neutral” rating in a report on Friday, January 5th. KeyCorp assumed coverage on Becton Dickinson and in a report on Friday, January 5th. They issued an “overweight” rating and a $260.00 price objective for the company. Finally, Evercore ISI assumed coverage on Becton Dickinson and in a report on Wednesday, January 3rd. They issued an “outperform” rating and a $245.00 price objective for the company. Four investment analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $233.80.

ILLEGAL ACTIVITY NOTICE: “Beck Mack & Oliver LLC Invests $216,000 in Becton Dickinson and Co (BDX)” was originally reported by Stock Observer and is the sole property of of Stock Observer. If you are reading this story on another website, it was stolen and republished in violation of US and international trademark and copyright laws. The correct version of this story can be read at https://www.thestockobserver.com/2018/02/06/beck-mack-oliver-llc-invests-216000-in-becton-dickinson-and-co-bdx.html.

About Becton Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton Dickinson and Co (NYSE:BDX).

Institutional Ownership by Quarter for Becton Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply